[1]徐中琪,甘 伟,刘 晟,等.经皮热消融治疗术后复发型肝内胆管细胞癌疗效分析[J].介入放射学杂志,2016,(11):973-976.
 XU Zhong- qi,GAN Wei,LIU Sheng,et al.Percutaneous thermal ablation for the treatment of recurrent intrahepatic cholangio carcinoma: analysis of curative effect[J].journal interventional radiology,2016,(11):973-976.
点击复制

经皮热消融治疗术后复发型肝内胆管细胞癌疗效分析 ()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2016年11期
页码:
973-976
栏目:
非血管介入
出版日期:
2016-11-25

文章信息/Info

Title:
Percutaneous thermal ablation for the treatment of recurrent intrahepatic cholangio carcinoma: analysis of curative effect
作者:
徐中琪 甘 伟 刘 晟 钱国军
Author(s):
XU Zhong- qi GAN Wei LIU Sheng QIAN Guo- jun
Section I, Department of Minimally Invasive Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China
关键词:
【关键词】 肝内胆管细胞癌 复发 热消融 超声引导 预后因素
文献标志码:
A
摘要:
【摘要】 目的 探讨超声引导下经皮热消融治疗术后复发型肝内胆管细胞癌(RICC)的疗效及预后相关因素。方法 2007年10月至2012年10月,37例RICC患者共60个结节接受经皮热消融治疗,并对患者的生存预后及影响因素进行回顾性分析。结果 57个结节(57/60,95%)完全消融;37例患者消融后无瘤生存期1.5~34.2个月(中位5.6个月);6个月、1年、2年和3年总生存率分别为94.6%、67.6%、40.5%和27.0%。单因素及多因素分析显示复发灶直径是影响消融后累积生存率的主要危险因素(P<0.001);多因素分析显示复发灶直径>3.0 cm(P=0.005)和术后早期复发(<1年)(P=0.036)是影响消融后无瘤生存期的独立危险因素。结论 经皮热消融治疗术后复发型肝内胆管细胞癌安全可行、疗效显著;术后复发灶大小是最重要的预后因素。

参考文献/References:

[1] Ustundag Y, Bayraktar, Y. Cholangiocarcinoma: a compact review of the literature[J]. World J Gastroenterol, 2008, 14: 6458- 6466.
[2] Saiura A, Yamamoto J, Kokudo N, et al. Intrahepatic cholangiocar- cinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections[J]. Am J Surg, 2011, 201: 203- 208.
[3] Facciorusso A, Di Maso M, Muscatiello N. Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta- analysis[J]. Int J Hyperthermia, 2016, 32: 339- 344.
[4] 经 翔, 丁建民, 王彦冬, 等. 射频消融和微波消融治疗肝癌的比较[J]. 介入放射学杂志, 2014, 23: 306- 310.
[5] 王 燕, 徐辉雄, 吕明德, 等. 超声引导经皮热消融治疗肝内胆管细胞癌[J]. 中华肝胆外科杂志, 2011, 17: 539- 542.
[6] 张德东, 于晓玲, 梁 萍, 等. 经皮微波消融治疗肝内胆管细胞癌的疗效分析[J]. 中华医学超声杂志?电子版, 2011, 8: 2314- 2319.
[7] Butros SR, Shenoy- Bhangle A, Mueller PR, et al. Radiofrequency ablation of intrahepatic cholangiocarcinoma: feasability, local tumor control, and long- term outcome[J]. Clin Imaging, 2014, 38: 490- 494.
[8] Song SC, Heo JS, Choi DW, et al. Survival benefits of surgical resection in recurrent cholangiocarcinoma[J]. J Korean Surg Soc, 2011, 81: 187- 194.
[9] Herber S, Otto G, Schneider J, et al. Transarterial chemoembo- lization(TACE) for inoperable intrahepatic cholangiocarcinoma[J]. Cardiovasc Intervent Radiol, 2007, 30: 1156- 1165.
[10] Lim JH, Park CK. Pathology of cholangiocarcinoma[J]. Abdom Imaging, 2004, 29: 540- 547.
[11] Kim JH, Won HJ, Shin YM, et al. Radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection[J]. Eur J Radiol, 2011, 80: e221- e225.
[12] Fu Y, Yang W, Wu W, et al. Radiofrequency ablation for postoperative recurrences of intrahepatic cholangiocarcinoma[J]. Chin J Cancer Res, 2011, 23: 295- 300.
[13] Huo TI, Lui WY, Wu JC, et al. Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence[J]. World J Surg, 2004, 28: 258- 262.
[14] Zhang SJ, Hu P, Wang N, et al. Thermal ablation versus repeated hepatic resection for recurrent intrahepatic cholangiocar- cinoma[J]. Ann Surg Oncol, 2013, 20: 3596- 3602.
[15] Sotiropoulos GC, Lang H, Broelsch CE. Surgical management of recurrent intrahepatic cholangiocellular carcinoma after liver resection[J]. Surgery, 2005, 137: 669- 670.

相似文献/References:

[1]杨熙章,吴纪瑞,杨永岩,等.灌注化疗预防肝癌术后复发[J].介入放射学杂志,1999,(02):32.
[2]许晓泉,施海彬,刘   圣,等. 外伤性颈动脉海绵窦瘘球囊栓塞术后复发危险因素分析及治疗[J].介入放射学杂志,2011,(12):931.
 XU Xiao-quan,SHI Hai-bin,LIU Sheng,et al.The analysis of risk factors and the treatment of recurrent traumatic carotid cavernous fistulas previously managed with detachable balloons[J].journal interventional radiology,2011,(11):931.
[3]顾俊鹏,顾 朋,迪力木拉提?巴吾东,等. 大咯血的介入治疗及复发的影响因素分析[J].介入放射学杂志,2012,(11):952.
 GU Jun? peng,GU Peng,DilimulatiBawudong,et al. The interventional management of massive hemoptysis and the analysis of factors influencing its recurrence[J].journal interventional radiology,2012,(11):952.
[4]胡 萍,司同国,郭 志.血清高迁移率族蛋白B1检测在T3N0M0期前列腺癌冷冻治疗后复发中的意义[J].介入放射学杂志,2013,(04):298.
 HU Ping,SI Tong? guo,GUO Zhi..The significance of serum HMGB1 in forecasting the recurrence of stage T3N0M0 prostate cancer after cryotherapy[J].journal interventional radiology,2013,(11):298.
[5]徐国斌,易广新,熊斌,等.原发性肝癌术后早期肝内复发转移36例的介入治疗[J].介入放射学杂志,2013,(04):325.
 XU Guo? bin,YI Guang? xin,XIONG Bin,et al.Interventional treatment of early intrahepatic recurrence or metastasis of primary liver carcinoma after surgical resection: initial experience of 36 cases[J].journal interventional radiology,2013,(11):325.
[6]任国荣,姜 平,曹枭强,等. 基于CT的三维颈内动脉瘤手术前后的血流动力学分析[J].介入放射学杂志,2013,(10):825.
 REN Guo? rong,JIANG Ping,CAO Xiao? qiang,et al. Hemodynamic analysis of preoperative and postoperative carotid aneurysm by using CT 3- D numerical simulation[J].journal interventional radiology,2013,(11):825.
[7]宗迎迎,徐 浩,许 伟,等.经肝动脉化疗栓塞联合经皮微波消融序贯治疗早期肝癌的疗效及预后影响因素[J].介入放射学杂志,2015,(03):210.
 ZONG Ying ying,XU Hao,XU Wei,et al.Sequential therapy of TACE followed by percutaneous microwave coagulation for early stage primary hepatocellular carcinomas: curative effect and prognostic factors[J].journal interventional radiology,2015,(11):210.
[8]任 炜,杨 薇.射频消融治疗复发性肝癌疗效及预后因素分析[J].介入放射学杂志,2015,(10):923.
 REN Wei,YANG Wei.Radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma: analysis of the therapeutic results and prognostic factors[J].journal interventional radiology,2015,(11):923.
[9]李婉慈,朱晓黎,王万胜,等.中晚期肝内胆管细胞癌介入治疗的临床疗效分析[J].介入放射学杂志,2016,(09):813.
 LI Wan- ci,ZHU Xiao- li,WANG Wan- sheng,et al.Clinical curative effect analysis of interventional therapy for advanced intrahepatic cholangiocarcinomas[J].journal interventional radiology,2016,(11):813.
[10]王 猛,魏 宁,徐 浩,等.腰椎间盘突出症臭氧消融术后短期内复发的危险因素[J].介入放射学杂志,2016,(11):977.
 WANG Meng,WEI Ning,XU Hao,et al.Risk factors for the short- term recurrence of protrusion of lumbar intervertebral disc after ozone ablation[J].journal interventional radiology,2016,(11):977.
[11]徐中琪,甘 伟,钱国军.复发性肝内胆管细胞癌治疗现状[J].介入放射学杂志,2016,(09):834.
 XU Zhong- qi,GAN Wei,QIAN Guo- jun.The treatment of recurrent intrahepatic cholangiocarcinomas: its present situation[J].journal interventional radiology,2016,(11):834.

备注/Memo

备注/Memo:
(收稿日期:2015-12-29)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2016-11-22